Join us!

We need to change the conversation on women, chest pain and coronary artery disease (CAD). Two leading experts will review women’s unique biology, risk factors, and presenting symptoms of heart disease during this webinar. They also will discuss better ways to detect and diagnose CAD, and how cardiac CT and FFRCT can identify those at-risk and in need of treatment. Join us to learn how cardiovascular (CV) teams can identify women at risk of CAD who are most likely to benefit from further testing and treatment.

Learning Objectives:

  • Discuss gaps in current CV care for women
  • Gather insight on gender-based differences in care
  • Understand why CAD diagnosis and treatment is slower in women than men
  • Review the 2021 Chest Pain Guideline and data supporting the use of a coronary CTA +/- FFRCT pathway and its benefits specifically for women 
  • Highlight the need for diagnostic strategies tailored to women 
  • Discuss how CCTA + FFRCT and Plaque can potentially remove bias during diagnosis and treatment 
  • Consider how a CT-first pathway enables a more efficient and timely diagnosis in women
  • Discuss how lesion-specific physiologic assessment provides more actionable information to treat women with non-obstructive disease

Who should attend: 

  • Cardiologists
  • Interventional Cardiologists
  • General Practitioners
  • NPs
  • PAs
  • CV Nurses
  • Cardiovascular Imaging Specialists
  • Cardiovascular Service Line Directors
  • Cath Lab Directors
  • CT Technologists

Expert Presenters: 

Dr Shaw

Leslee Shaw, PhD
Professor of Medicine in Cardiology, Population Health Science, and Obstetrics, Gynecology, and Reproductive Science at Icahn School of Medicine at Mount Sinai and Director of the Blavatnik Family Women's Health Research Institute

Dr Gulati

Martha Gulati, MD,
Director, Preventive Cardiology and Associate Director, Barbra Streisand Women’s Heart Center; Associate Director, Preventive and Cardiac Rehabilitation Center; Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine & Research, Smidt Heart Institute; President, American Society for Preventive Cardiology, Cedars Sinai